Skip to main content
OpenTrials
Completed

NCT Number: NCT02305680

Long-term Follow-up of antithrombotIc Management Patterns in Acute Coronary Syndrome Patients in Asia-China Extension

This study is to describe the long-term antithrombotic management patterns in a real-life setting for patients hospitalized with an acute coronary syndrome in China.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acute Coronary Syndromes Acute Coronary Syndrome Cardiovascular Diseases Heart Diseases Myocardial Ischemia Vascular Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Baoding, China

Loading trial locations.

About this study

This study is to describe the long-term (3 to 5 years after the acute coronary syndrome index event) antithrombotic management patterns in a real-life setting for patients hospitalized with an acute coronary syndrome (i.e. ST-segment Elevation Myocardial Infarction, Non-ST-segment Elevation Myocardial Infarction, Unstable Angina) in China.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Written informed consent has been provided.
  • Contact Order Form has been provided
  • Aged 18 years or older.
  • Enrolled in EPICOR Asia study and completed the 2 year follow-up.

Exclusion criteria

  • Presence of any condition/circumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient (e.g. tourist, non-native speaker or does not understand the local language, psychiatric disturbances, alcohol or drug abuse).
  • Already included in the EPICOR Asia-China Extension observational study.
  • Presence of serious/severe co-morbidities in the opinion of the investigator which may limit short term (i.e. 6 month) life expectancy.
  • Current participation in an interventional clinical trial.
  • Patients receiving ticagrelor beyond 12 months and other off label use.

Treatment and study plan

Primary outcomes

  1. Long-term antithrombotic management patterns in a real-life setting by assessing the medication and treatment prescribed by physicians

    Time frame: From 2 years after the acute coronary syndrome index event, assessed up to 5 years

Secondary outcomes

  1. Clinical outcomes by record the number and type of cardiovascular and non-cardiovascular events

    Time frame: From 2 years after the acute coronary syndrome index event, assessed up to 5 years

  2. Health care resource consumption and related costs by assessing the detail hospitalization and outpatient cost.

    Time frame: From 2 years after the acute coronary syndrome index event, assessed up to 5 years

  3. Quality of life by assessing EQ-5D questionnaire.

    Time frame: 2 years,2.5years,3years,3.5years,4years,4.5years,5years after the acute coronary syndrome index event

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

EPICOR Asia-China Extension. Long-term Follow-up of antithrombotIc Management Patterns in Acute Coronary Syndrome Patients in Asia-China Extension

Acronym: EPICOR

Important dates

Study start
2014
Primary completion
2017
Study completion
2017
First posted
Dec 3, 2014
Registry last updated
Sep 17, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.